These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 28792289)

  • 1. A guide to psychopharmacological treatment of patients with intellectual disability in psychiatry.
    Molina-Ruiz RM; Martín-Carballeda J; Asensio-Moreno I; Montañés-Rada F
    Int J Psychiatry Med; 2017 Mar; 52(2):176-189. PubMed ID: 28792289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychopharmacotherapy in children and adults with intellectual disability.
    Santosh PJ; Baird G
    Lancet; 1999 Jul; 354(9174):233-42. PubMed ID: 10421318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The international consensus process on psychopharmacology and intellectual disability.
    Reiss S; Aman MG
    J Intellect Disabil Res; 1997 Dec; 41 ( Pt 6)():448-55. PubMed ID: 9430048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychopharmacology research for individuals with mental retardation: methodological issues and suggestions.
    Matson JL; Bielecki J; Mayville SB; Matson ML
    Res Dev Disabil; 2003; 24(3):149-57. PubMed ID: 12742384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of psychiatric morbidity in the mentally retarded adult.
    Lund J
    Acta Psychiatr Scand; 1986 Apr; 73(4):429-36. PubMed ID: 2873716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of Psychotropic Polypharmacy Among Outpatients With Psychiatric Disorders and Intellectual Disability.
    Lunsky Y; Modi M
    Psychiatr Serv; 2018 Feb; 69(2):242-246. PubMed ID: 29089006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unmet needs in paediatric psychopharmacology: Present scenario and future perspectives.
    Persico AM; Arango C; Buitelaar JK; Correll CU; Glennon JC; Hoekstra PJ; Moreno C; Vitiello B; Vorstman J; Zuddas A;
    Eur Neuropsychopharmacol; 2015 Oct; 25(10):1513-31. PubMed ID: 26166453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in the use of psychotropic drugs in people with intellectual disability in Taiwan: a nationwide outpatient service study, 1997-2007.
    Hsu SW; Chiang PH; Chang YC; Lin JD; Tung HJ; Chen CY
    Res Dev Disabil; 2014 Feb; 35(2):364-72. PubMed ID: 24333807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychotropic prescribing in people with intellectual disability and challenging behaviour.
    Sheehan R; Strydom A; Morant N; Pappa E; Hassiotis A
    BMJ; 2017 Aug; 358():j3896. PubMed ID: 28821479
    [No Abstract]   [Full Text] [Related]  

  • 10. Philosophy of clinical psychopharmacology.
    Aragona M
    Psychiatr Danub; 2013 Mar; 25(1):4-10. PubMed ID: 23470600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effectiveness of psychosocial interventions for children with a psychiatric disorder and mild intellectual disability to borderline intellectual functioning: A systematic literature review and meta-analysis.
    Kok L; van der Waa A; Klip H; Staal W
    Clin Child Psychol Psychiatry; 2016 Jan; 21(1):156-71. PubMed ID: 25633367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mental illness, challenging behaviour, and psychotropic drug prescribing in people with intellectual disability: UK population based cohort study.
    Sheehan R; Hassiotis A; Walters K; Osborn D; Strydom A; Horsfall L
    BMJ; 2015 Sep; 351():h4326. PubMed ID: 26330451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mentoring treatment teams to integrate behavioral and psychopharmacological treatments in developmental disabilities.
    Singh NN; Wahler RG; Sabaawi M; Goza AB; Singh SD; Molina EJ; Winton AS; Strand PS; Hill OW; Singh J; Barber JW; El-Sabaawi M; Dumas J;
    Res Dev Disabil; 2002; 23(6):379-89. PubMed ID: 12426007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychiatric and behavioural disorders amongst older severely mentally handicapped inpatients.
    James DH
    J Ment Defic Res; 1986 Dec; 30 ( Pt 4)():341-5. PubMed ID: 3806661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Psychopharmacological treatment of suicidal process].
    Mussa A
    Vertex; 2011; 22(100):435-43. PubMed ID: 22799145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of psychotropic drugs in children, adolescents and subjects with intellectual disability: a review].
    Lazzeretti L; Pracucci C; Benni L; Godini L; Talamba GA; Faravelli C
    Riv Psichiatr; 2011; 46(1):1-17. PubMed ID: 21446107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychopharmacology and mental retardation: a 10 year review (1990-1999).
    Matson JL; Bamburg JW; Mayville EA; Pinkston J; Bielecki J; Kuhn D; Smalls Y; Logan JR
    Res Dev Disabil; 2000; 21(4):263-96. PubMed ID: 10983783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacotherapy for mental health problems in people with intellectual disability.
    Ji NY; Findling RL
    Curr Opin Psychiatry; 2016 Mar; 29(2):103-25. PubMed ID: 26779860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychopharmacology of Williams syndrome: safety, tolerability, and effectiveness.
    Thom RP; Pober BR; McDougle CJ
    Expert Opin Drug Saf; 2021 Mar; 20(3):293-306. PubMed ID: 33369485
    [No Abstract]   [Full Text] [Related]  

  • 20. Psychotropic medication for behaviour problems in people with intellectual disability: a review of the current literature.
    Deb S; Unwin GL
    Curr Opin Psychiatry; 2007 Sep; 20(5):461-6. PubMed ID: 17762588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.